SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Bogdanoff who wrote (938)5/31/1999 12:25:00 AM
From: Awashonks  Read Replies (1) of 1060
 
I am sorry, I must have not been clear. The present PhaseII trial tested patients with steroid-induced glaucoma. The next Phase II trial will test an expanded indication. It will test patients with all other types of glaucoma. My understanding is that they expect the trial to go well given the indications in the original Phase II trial.

For further info, call Sandi Heine at ISV, she is very helpful.

All the best,

Awashonks
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News